Related Experiment Video

Updated: Oct 16, 2026

Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling
09:33

Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling

Published on: March 20, 2018

Effects of metabolites of benzo(a)pyrene on unschedule DNA synthesis in BALB/3T3 cell line

J K Chen1, Z L Wu, Y G Liu

  • 1Institute for Chemical Carcinogenesis, Guangzhou Medical College, People's Republic of China.

Chemosphere
|May 20, 2000
PubMed

Insights

Metabolites of benzo(a)pyrene, including anti-BPDE and 3-OH-BP, damage mammalian cell DNA by increasing DNA synthesis and inducing unscheduled DNA synthesis (UDS). This DNA damage is linked to the specific structure of these benzo(a)pyrene metabolites.

Area of Science:

  • Toxicology
  • Molecular Biology
  • Environmental Health

Background:

  • Benzo(a)pyrene is a polycyclic aromatic hydrocarbon found in environmental pollutants.
  • Metabolites of benzo(a)pyrene can interact with cellular DNA, potentially causing damage.
  • Understanding the genotoxicity of these metabolites is crucial for assessing health risks.

Purpose of the Study:

  • To investigate the DNA damaging effects of four specific benzo(a)pyrene metabolites on mammalian cells.
  • To determine if these metabolites affect DNA synthesis and induce unscheduled DNA synthesis (UDS).
  • To explore the relationship between the structure of benzo(a)pyrene metabolites and their genotoxic potential.

Main Methods:

  • Utilized BALB/3T3 mammalian cells for experimental assays.
  • Employed single-labeling and double-labeling techniques to measure DNA synthesis.
  • Assessed unscheduled DNA synthesis (UDS) in response to metabolite exposure.

Main Results:

  • All four tested benzo(a)pyrene metabolites (anti-BPDE, syn-BPDE, 3-OH-BP, 9-OH-BP) increased DNA synthesis in BALB/3T3 cells.
  • Three of the four metabolites (anti-BPDE, 3-OH-BP, 9-OH-BP) induced unscheduled DNA synthesis (UDS).
  • Syn-benzo(a)pyrene diol epoxide (syn-BPDE) did not induce UDS, suggesting structural specificity.

Conclusions:

  • Metabolites of benzo(a)pyrene demonstrably damage DNA in mammalian cells.
  • The induction of UDS by specific metabolites indicates DNA repair mechanisms are activated.
  • The sterical structure of benzo(a)pyrene metabolites plays a significant role in their ability to cause DNA damage.

More Related Videos

The Lambda Select cII Mutation Detection System07:08

The Lambda Select cII Mutation Detection System

Published on: April 26, 2018

Unveiling Xenobiotic Transport and Effects in Isolated Mitochondria: Insights from Respirometric and Enzymatic Assays08:03

Unveiling Xenobiotic Transport and Effects in Isolated Mitochondria: Insights from Respirometric and Enzymatic Assays

Published on: March 7, 2025

Related Concept Videos

Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
Biosynthesis of Nucleic Acids01:28

Biosynthesis of Nucleic Acids

Nucleic acid biosynthesis is a fundamental biochemical process that produces the purine and pyrimidine nucleotides essential for DNA and RNA synthesis. This pathway maintains a balanced nucleotide pool, preventing imbalances that could jeopardize genetic integrity and cellular function. Given the crucial role of nucleotides, their synthesis is tightly regulated to ensure proper cellular homeostasis.Purine BiosynthesisThe biosynthesis of purine nucleotides begins with ribose-5-phosphate, a...
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase01:27

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
Bioactivation and Tissue Toxicity01:25

Bioactivation and Tissue Toxicity

Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...